Status
Conditions
Treatments
About
Abstract Objective The purpose of this study was to analyze the factors affecting the occurrence of peri-implant inflammation in patients with oral implant repair, and to explore the effect of subgingival sandblasting technology on the maintenance of microecology around the implant, so as to provide a basis for optimizing clinical prevention and treatment strategies.
Method Ninety-six patients with early periimplantitis treated in our hospital from July 2022 to July 2024 were selected as the inflammation group. All patients were randomly divided into control group, glycine subgingival sandblasting group and erythritol subgingival sandblasting group (n=32). The clinical therapeutic effect of the two groups was compared. A total of 102 patients who underwent oral implant repair in our hospital during the same period without peri-implant inflammation were selected as the group without inflammation. The independent risk factors of peri-implant inflammation were analyzed.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria Clinical diagnosis of peri-implantitis (PD ≥4 mm with BOP/suppuration)
At least one functional dental implant in place for ≥6 months
Willing and able to maintain standard oral hygiene protocol
No antibiotic or anti-inflammatory drug use in the past 30 days
Absence of uncontrolled systemic diseases (e.g., diabetes, hypertension)
Complete baseline clinical data available (medical history, radiographs, lab results)
Exclusion Criteria Acute oral infections requiring immediate treatment
History of radiation therapy to the head/neck region
Severe uncontrolled periodontal disease
Active malignancy or current cancer treatment
Coagulation disorders or anticoagulant therapy
Pregnancy or lactation
Cognitive impairment affecting compliance
Allergy to glycine or erythritol compounds
Non-Inflammatory Group Additional Criteria Successful implant placement with no signs of inflammation (PD ≤3 mm, no BOP)
Matched to study group by age (±5 years) and implant location
Meets all other inclusion/exclusion criteria regarding systemic health
Note: All participants must provide informed consent. Healthy volunteers without implants are not eligible.
Primary purpose
Allocation
Interventional model
Masking
96 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal